ABSTRACT Microbes are vital in human health. It is helpful to promote diagnostic and treatment of human disease and drug development by identifying microbe-disease associations. However, knowledge in this area still needs to be further improved. In this paper, a new computational model using matrix completion to predict human microbe-disease associations (mHMDA, Fig. 1 ) is developed. First, we extract the disease feature by Gaussian kernel-based similarity and symptom-based similarity. Meanwhile, the microbe feature is computed by Gaussian kernel-based similarity. As treating potential association as the missing elements of a matrix, the matrix completion is adopted to get the potential microbe-disease associations. Leave-one-out cross-validation (LOOCV) is carried out which get the AUC (The area under ROC curve) of 0.928 showing the effectiveness of mHMDA. Furthermore, 5-fold CV get the AUCs of 0.8838 ± 0.0044 (mean ± standard deviation). Moreover, through the four case studies (asthma, inflammatory bowel disease (IBD), type 2 diabetes (T2D), and type 1 diabetes (T1D)), we find that nine, ten, nine, and eight of top-ten inferred microorganisms for the four diseases are previously verified by experiments. All these results indicate the effectiveness of mHMDA. mHMDA might be helpful to infer the disease-related microorganisms.
I. INTRODUCTION
Microorganisms are very important to human health [1] , [2] . Numerous lab experiments and clinic studies have found novel links between human diseases and microbes.
It will be helpful to explore the pathogenesis of diseases and prevent or treat diseases by studying the interactions of microbes and diseases (MD). To aid experiments, many computational methods were developed to exploit new relationship between microorganisms and diseases. HMDAD (human microbe-disease associations database) provides basic knowledge of the MD associations [3] . With the knowledge of this database, many models were proposed. Some prediction methods were developed by Gaussian similarity [4] . For instance, KATZHMDA adopted KATZ method to find potential MD associations [5] . PBHMDA was proposed to treat associations as links between microbes and diseases by searching depth firstly algorithm [6] . Some researchers used the matrix factorization technique to investigate the association, such as CMFHMDA utilizing factorization of the collab-
The associate editor coordinating the review of this manuscript and approving it for publication was Vincenzo Conti. orative matrix to predict novel association [7] . Furthermore, Random Walk (RW) and its improved algorithms were utilized to get the probabilities of MD association. For instance, RWRHMDA [8] , BiRWHMDA [9] , and PRWHMDA [10] were recently developed tools utilizing RW methods on the MD network. Moreover, some researches focused on sample processing. ABHMDA utilized k-means to balance the samples to train a model to get the possible links between diseases and microbes [11] . MDPH_HMDA calculated the HeteSim measure on the heterogeneous graph fusing three levels of networks [12] . All of these efforts were to improve the identification of novel MD associations.
However, the efficiency of identifying MD associations requires to be further improved. This study is to present a computational model to infer candidate MD associations with the knowledge of the known associations. In this paper, we put forward a computational model using matrix completion to predict human microbe-disease associations (mHMDA, Fig. 1 ). For disease feature, we calculate the disease similarity by Gaussian kernel-based and symptom-based similarities. Then we combine the two similarities together to reflect the feature of diseases in different aspects. Meanwhile, the Gaussian kernel-based similarity are utilized to calculate the microbe feature. Matrix completion is adopted to recover the missing associations between microbes and diseases. Cross-validations (CV) including LOOCV (leave-one-out cross-validation) and 5-fold CV, comparison with state-of-the-art methods, and case studies are implemented to measure the performance of mHMDA. For LOOCV, the AUC is 0.928, while it is 0.8838 ± 0.0044 (mean ± standard deviation) for 5-fold CV. The CVs show the effectiveness of mHMDA. In four case studies (asthma, IBD, T2D, and T1D), more than eight of top-ten inferred microbes have been experimentally verified for each disease. The results show that mHMDA is effective to identify disease-related microorganisms.
The structure of this paper is as follows: The dataset used in this study is depicted in the Material section. We describe MD feature calculation and the mHMDA model in the Methods section. The results of LOOCV, 5-fold CV, comparison with other existing models and the top ten inferred microbes of four diseases are given in the Results section. The results are discussed and the work is concluded in the Discussion and Conclusion part.
II. MATERIAL
HMDAD [3] was adopted in the study as basic knowledge. In HMDAD, there are N m = 292 microbes, N d = 39 diseases, and 483 associations between them. Removing the repetitive associations, 450 unique associations remained. Moreover, Human Symptom Disease Network (HSDN) [13] was used to calculate the symptom-based disease similarity.
III. METHODS

A. DISEASE FEATURE
Gaussian kernel-based similarity comes to one if two vectors are identical, and approaches zero as they move apart. In order to extract the feature of the disease, we calculated the Gaussian kernel-based similarity with the information from HMDAD. Furthermore, the symptom-based similarity of diseases is calculated according to the disease symptom term co-existence information in PubMed.
Firstly, let a binary vector MS(d i ) denote the association information of the specific disease i with each microbe. The interactions of disease i with all the microbes denoted by MS(d i ) can be calculated as follows
where M j (d i ) denotes whether disease i is related to the specific microbe j. M j (d i ) can be calculated as
1 microbe j has relation with disease i, 0 otherwise.
1) GAUSSIAN KERNEL-based DISEASE SIMILARITY
The Gaussian kernel disease-disease similarity is
where
) denotes the similarity between diseases i and j calculated as
and γ d denotes the normalized bandwidth based on initial bandwidth γ d which we set the value as 4.
2) SYMPTOM-BASED DISEASE-DISEASE SIMILARITY
The symptom-based human disease network (HSDN) [13] can compute disease similarity according to the symptom and disease information in PubMed. The symptom-based disease similarity (SD_S) is introduced into mHMDA model to compute the similarity of diseases. Thus, the total disease feature S d is computed by
where alpha, beta are the weights of Gaussian kernel-based similarity and symptom-based similarity, respectively.
B. MICROBE FEATURE
It is assumed that microbes sharing similar diseases tend to be functionally similar. Suppose the interactions of microbe i with all the diseases represented by DS(m i ) can be calculated as follows
where D j (m i ) denotes whether disease j is related to the specific microbe i. D j (m i ) can be calculated as D j (m i ) = 1 disease j has relation with microbe i, 0 otherwise.
1) GAUSSIAN KERNEL-BASED MICROBE SIMILARITY
The Gaussian kernel-based similarity for microbes is
where sm g (m i , m j )(i, j = 1, 2, . . . , N m ) denotes the Gaussian kernel-based similarity between microbes i and j calculated as
γ m denotes the normalized bandwidth based on initial bandwidth γ m which we set the value as 4. Thus, the total microbe feature S m is computed by
C. mHMDA
Matrix completion method recovering a low-rank matrix from a partial sampling of its entries has been widely used in many fields such as collaborative filtering for recommendation [14] , multi-label learning [15] , [16] and clustering [17] and link prediction [18] , [19] . Inspired by this, we designed to recover a matrix using the known elements of MD associations. By feature extraction, we can get the human MD associ-
Since experimentally verified associations are very few, the matrix A is very sparse. The potential associations are treated as missing relationships. The target of our study is to complete the missing elements of A with the supervision of matrix A. The recovered matrix with missing relationships can be denoted asÃ
and S m is the feature of microbes, k is the minimum rank of W and H . W and H can be obtained by optimizing
where [20] is utilized to solve the minimum problem. W and H initialized with the random dense matrix can be updated by the iterative equations (10) and (11) until convergence. The iterative equations of W and H are
Finally, the probability of having associations between disease i and microbe j can be calculated by applying W and
IV. RESULTS
A. RESULTS OF SIMILARITY
In HMDAD, the distribution of associations is shown in Fig. 2 (a) and 2(b). In Fig. 2(a) , X-axis denotes the association number, while the Y-axis denotes the number of disease had this number of associations. Fig. 2(a) and Fig. 2(b) indicate that there are 38.46% of diseases (15 diseases) having only one associated microbe. Therefore, some information besides HMDAD is required. Thus, we introduce the symptom-based disease feature which is calculated based on the co-existence of diseases and symptoms. Gaussian kernel-based similarity is a measurement of similarity between two vectors, which is one if they are identical, and approaches 0 as they move further apart. Considering of this, we calculated the Gaussian kernel-based disease similarity using the interaction profile. Furthermore, symptom-based disease similarity is calculated based on the co-existence of diseases and symptoms. The two kinds of similarity reflect different features of diseases. The Gaussian kernel-based similarity of diseases is shown in Fig. 3(a) . Symptom-based disease similarity is shown in Fig. 3(b) . Fig. 3 (a) and 3(b) show that by these two similarities, we can get more information. Combining these similarities (α = 0.9, β=0.1), the disease feature reflects much more information (Fig. 3(c) ).
B. CROSS VALIDATION
LOOCV was performed on the known MD associations from HMDAD. In each round, one known MD association is recruited to test the model trained by the other remaining associations. This is repeated until all the known associations are tested. The test sample is then ranked according to the prediction score in all unverified MD associations. After obtaining the score for each pair, the Receiver Operating Characteristic (ROC) curve can be plotted, with the x-axis representing the false positive rate (FPR) and the y-axis representing the true positive rate (TPR). TPR and FPR vary according to the threshold as a predictive criterion. For a specific threshold, the TPR is calculated as the ratio of the number of correctly predicted positive samples (i.e., having a higher score than a particular threshold) to the number of all positive samples. While FPR refers to the ratio of the number of correctly predicted negative samples to the number of all negative samples. The area under the ROC Curve (AUC) as a metric of the model is calculated to measure the performance. Finally, LOOCV AUC reached 0.928 (Fig. 4 in gray line) . Furthermore, 5-fold CV was implemented by randomly dividing the MD associations of HMDAD into five groups with no overlap. Of the five groups, four are used to train the model, and the remaining one is used to test the model. This process is repeated until all groups have been tested. To measure the robustness, 5-fold CV was repeated 100 times. Finally, it gets the result of 0.8838 ± 0.0044 (mean AUC ± standard deviation). 
C. COMPARISON WITH OTHER METHODS
LOOCV of some state-of-the-art methods (KATZHMD [5] , RW3RHMDA [8] , BiRWHMDA [9] , and PRWHMDA [10] ) were also implemented on the same data. The ROCs are shown in Fig. 4 . The AUCs of the four methods are 0.8112, 0.8332, 0.8964, and 0.915, respectively. The comparison shows that mHMDA gets a better ROC with relatively higher AUC.
D. CASE STUDIES OF NOVEL ASSOCIATIONS
In this section, we apply mHMDA to four diseases to infer related microbes as case studies.
1) ASTHMA
By mHMDA, we obtained the top-ten related microbes of asthma (Table 1) . Among them, nine predicted associations have been experimentally verified. Lactobacillus, Actinobacteria, Lachnospiraceae, and Firmicutes (1st, 2nd, 5th, and 7th predicted association) were reported to be lower in asthmatic than non-asthmatics [21] , while Pseudomonas, Burkholderia, clostridium(3rd, 6th, 9th predicted association) were found to be over-represented in asthmatics [22] , [23] . Clostridium coccoides (4th predicted association) species was reported as an early predictor of developing asthma [24] . Streptococcus (8th predicted association) might affect the development of asthma [25] .
2) INFLAMMATORY BOWEL DISEASE
By mHMDA, we obtained the top-ten related microbes of inflammatory bowel disease (IBD) ( Table 2 ). All of the topten microbes in Table 2 have been verified by published work. Clostridium coccoides, Bacteroidetes, Alistipes, and Rikenellaceae(1st, 2nd, 8th, 10th predicted association) were less enriched in IBD patients than in healthy subjects [26] - [28] , whereas Streptococcus, Firmicutes (3rd, 5th predicted association) were significantly increased [28] . Prevotella (4th predicted association) was found to be associated with dysbacteriosis in IBD patients [29] . A recent study showed that Lactobacillus (6th predicted association) could help control IBD [30] . Genus of Parabacteroides (9th of prediction association) was the most represented in Crohn patients [31] .
3) TYPE 2 DIABETES Table 3 showed the top-ten potential related microbes of T2D, 9 of which have been experimentally validated by previous work.
There were significant differences in the enrichment of Prevotella, Actinobacteria and Pseudomonas (1st, 2nd, 3rd predicted association) between diabetic and non-diabetic patients [32] . The species of Haemophilus, order of Bacteroidales, the family of Lachnospiraceae, andFusobacterium (4th, 5th, 8th, 9th predicted association) were highly enriched in the control samples [33] - [36] , while Fusobacterium nucleatum, andStaphylococcus aureus (7th and 10th predicted association) were detected significantly more often in diabetic subjects than in nondiabetics [36] , [37] .
4) TYPE 1 DIABETES
Besides the known associated microbes of T1D, we found some novel candidate microbes associated with T1D. Eight of the top-ten associations have been experimentally verified (Table 4) . VOLUME 7, 2019 Fusobacterium nucleatum, Clostridium, Pseudomonal, Enterobacteriaceae, Clostridium, Tannerella (1st, genus of 2nd, 4th, 7th, 9th, 10th inferred microbes) were found with higher enrichment in T1D group [39] - [43] , whereas the enrichment of Clostridium leptum (5th inferred microbe) was reduced [38] . It was identified that Faecalibacterium prausnitzii(8th inferred microbes) in the gut microbes was correlated with the development and onset of T1D [44] .
The four case studies show that mHMDA can be an effective tool to exploit potential MD associations. For all the diseases in HMDAD, the top-ten inferred related microbes are available in S1 File.
V. DISCUSSION AND CONCLUSION
mHMDA was proposed as a novel computational model with the knowledge of previously experimentally validated associations between diseases and microorganisms. To get the disease feature, Gaussian kernel-based and symptom-based similarities were computed. Then we combined the two similarities. To get the microbe feature, Gaussian kernel-based similarity is calculated. Then matrix completion was employed to recover the missing MD associations (possible associations). Apart from CVs (LOOCV and 5-fold CV), comparison, and case studies were carried out to verify the effectiveness of mHMDA. Finally, mHMDA got the AUCs of 0.928 (LOOCV) and 0.8838 ± 0.0044 (5-fold CV). The case researches show that more than 8 of top-ten inferred microbes have been experimentally verified to have associations with asthma, IBD, T2D, and T1D, respectively. It is believed that mHMDA could be helpful to identify novel MD associations.
The good performance of the proposed method may benefit from the following aspects. (1) Multi-source of information was introduced to calculate the disease feature. We used not only the information of HMDAD, but also the information on symptoms of the disease. (2) Matrix completion method as a semi-supervised learning method was utilized to recover the missing associations with validated microbe-disease associations.
However, there are some limitations to mHMDA. (1) The experimentally validated MD associations used to train the mHMDA are inadequate. For some disease, we have more associations, but most of the diseases have little known associations. This issue is expected to be resolved when more microbe-disease associations are available in the future. (2) Although for disease, we have used multi-source information. For microbe, some other substantial datasets such as microbe homologous sequence similarity should be used to enhance the reliability of microbe feature. We hope that mHMDA might aid medical experiments to get potential associations.
APPENDIX
The top-ten potential inferred microbes of the researched diseases are available in S1 File. 
